GLOBAL NEWBORN SCREENING MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL NEWBORN SCREENING MARKET FORECAST 2019-2027

GLOBAL NEWBORN SCREENING MARKET FORECAST 2019-2027

The global newborn screening market is estimated to grow from $649 million in 2018 to $1,977 million by 2027 at a CAGR of 13.56% between 2019 and 2027. The base year considered for the study is 2018 and the estimated period is between 2019 and 2027. Key factors that are responsible for the market advancement are:

GLOBAL NEWBORN SCREENING MARKET FORECAST 2019-2027

Global Newborn Screening Market By Product (new-born Screening Instruments, New-born Screening Reagents & Assay Kits) By Test Type (hearing Screen Test, Critical Congenital Heart Disease (cchd) Test, Dry Blood Spot Test) By Technology (tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, Dna Based Assays, Electrophoresis, Others) By Geography.

Request free sample

Newborn screening is a practice of testing all babies in their first days of life for certain disorders and conditions that can hinder their normal development. These tests are required in every country and are typically performed before the baby is discharged from the hospital. The conditions detected in newborn screening can cause serious health problems. Early detection and treatment can help prevent intellectual and physical disabilities and certain life-threatening illnesses.

Some of the conditions included in newborn screening programs are only detectable after irreversible damage; in some cases, sudden death is the first manifestation of a disease. The state or national governing bodies often run the screening programs with the goal of screening all infants born in the jurisdiction.

The global newborn screening market is estimated to grow from $XX million in 2018 to $1,977 million by 2027 at a CAGR of 13.56% between 2019 and 2027. The base year considered for the study is 2018 and the estimated period is between 2019 and 2027. Key factors that are responsible for the market advancement are:

  • Increase in occurrences of newborn diseases
  • A growing number of infants with a congenital disability
  • The backing of the government towards newborn child health
  • Rising awareness for pediatric congenital heart disease

However, the market is primarily driven by Increase in occurrences of newborn diseases. Newborn babies are more prone to infections which occur at any time from the first day of birth. The key factor driving the growth of global newborn screening market is the increasing prevalence of newborn diseases such as congenital anomalies, respiratory distress syndrome, neonatal infection, etc. This has led to the increased adoption of newborn screening equipment to diagnose fatal diseases in newborn babies. According to the United Nations Children’s Fund (UNICEF), children face the highest risk of dying in the first month of their life.

In terms of product segment, newborn screening instruments segment leads the market in terms of revenue with around XX% market share in 2018. The newborn screening instruments includes hearings screening instruments, newborn disorder screening instruments and pulse oximetry are useful in detecting diseases among newborn such as COPD, congenital heart diseases, galactosemia, etc. There is a demand of instruments and reagents in order to run a successful and cost-effective newborn screening test. These instruments are required to detect disorders accurately and efficiently in newborns.

Global newborn screening market is also facing some challenges with the absence of proper healthcare infrastructure for newborn babies in developing countries, socio-economic hurdles in the implementation of newborn child screening, the dearth of a skilled professional in healthcare industry & maintenance of equipment in the hospital. Lack of skilled professionals in the medical field makes the healthcare system unable to meet the demands of the growing population related to healthcare. Highly skilled health professionals play an important role in effective care and screening of newborn. Availability of healthcare professional at all levels of the healthcare system is really necessary for the national goal of Universal Health Coverage (UHC).

The newborn screening market segmented on the basis of product, test technology and technology:

Product is sub-segmented into:

  • New-born screening instruments
  • New-born screening Reagents & Assay kits

Test Technology is sub-segmented into:

  • Hearing screen test
  • Critical congenital heart disease (CCHD) Test
  • Dry blood spot test

Technology is sub-segmented into:

  • Tandem Mass Spectrometry
  • Pulse Oximetry
  • Enzyme-based assays
  • DNA based assays
  • Electrophoresis
  • Others

Geographically, the global newborn screening market has been segmented on the basis of four major regions, which includes:

The regional paradigm of global newborn screening market is dominated by North America region by capturing the largest market share in terms of revenue of XX% in 2018. North America newborn screening market is driven by compensatory rules & regulations of newborn screening market in the United States along with the presence of many newborn screening centers & rising hearing disorders in newborn babies in Canada. The newborn screening has its primary application in the detection and diagnosis of diseases that mainly occur in infants and newborn babies.

On the flip side, the Asia Pacific region is expected to surge with the fastest growth rate during the forecasted period. The Asia Pacific newborn screening market find its application in the healthcare sector with areas such as hospitals and diagnostic laboratories of Asia Pacific owing to its increasing adoption across countries such as China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand and Rest of Asia Pacific. Newborn screening market is on the surging trend in the Asia Pacific region owing to increasing birth rate, government programs supporting newborn screening, increasing prevalence of diseases in newborn babies, and increasing prevalence of congenital disabilities.

The global newborn screening market segmented by product, test technology and technology. By product is sub-segmented into new-born screening instruments & new-born screening reagents & assay kits. By test technology is sub-segmented into hearing screen test, critical congenital heart disease (CCHD) test & dry blood spot test. By technology is sub-segmented into tandem mass spectrometry, pulse oximetry, enzyme-based assays, dna based assays, electrophoresis & others.

The market has a number of players, and some of the key players involved in the global newborn screening market are:

  • Sciex
  • Biotek Instruments Inc.
  • Bio-Rad Laboratories Inc.
  • Cardinal Health Inc.
  • GE Healthcare Limited
  • Others

Market share analysis along with company profiles of the prominent market players are discussed in detail. Most of the companies are looking for strategies such as merger & acquisition, partnership, contracts, agreements, new product launch, to gain a competitive edge over other companies.

In January 2019, SCIEX, a global leader in life science analytical technologies, announced that the San Francisco Office of the Chief Medical Examiner (SFOCME) is transforming the City and County’s forensic testing with the addition of eight cutting-edge SCIEX systems to its analytical capabilities. The SFOCME has acquired three SCIEX X500R QTOF Systems and five SCIEX QTRAP® 6500+ LC-MS/MS Systems to accelerate caseloads and improve accuracy, both of which are essential for routine forensic investigations and the protection of public health.

Also, in January 2019, BioTek Instruments introduces their next generation Epoch™ 2 Microplate Spectrophotometer; with added features that enable multiple conveniences for performing absorbance measurements. Epoch 2 includes monochromator-based individual wavelength selection or wavelength scanning from 200-999 nm to accommodate an extensive range of assays, including nucleic acid and protein quantification, ELISA, microbial growth, endotoxin, ROS assays, and enzyme kinetics.

Key findings of the newborn screening market:

  • Supportive government policies in the US and Canada
  • Demand for newborn screening instruments is rising steadily
  • Growth in a dry blood spot test
  • Techniques used in newborn screening tests
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • SUPPORTIVE GOVERNMENT POLICIES IN US AND CANADA
      • DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
      • GROWTH IN DRY BLOOD SPOT TEST
      • TECHNIQUES USED IN NEWBORN SCREENING TESTS
  1. MARKET DYNAMICS
    • ETYMOLOGY OF NEWBORN SCREENING
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • INCREASE IN OCCURRENCES OF NEWBORN DISEASES
      • GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
      • BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
      • RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
    • MARKET RESTRAINTS
      • ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
      • SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
    • MARKET OPPORTUNITIES
      • INCREASING FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH
      • NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
      • TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
      • INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
    • MARKET CHALLENGES
      • DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
      • MAINTENANCE OF EQUIPMENT IN HOSPITAL
  1. MARKET BY PRODUCT
    • NEW-BORN SCREENING INSTRUMENTS
    • NEW-BORN SCREENING REAGENTS & ASSAY KITS
  2. MARKET BY TEST TYPE
    • HEARING SCREEN TEST
    • CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
    • DRY BLOOD SPOT TEST
  3. MARKET BY TECHNOLOGY
    • TANDEM MASS SPECTROMETRY
    • PULSE OXIMETRY
    • ENZYME BASED ASSAYS
    • DNA BASED ASSAYS
    • ELECTROPHORESIS
    • OTHERS
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
      • RELIABILITY
      • COST
      • AVAILABILITY
      • TECHNOLOGICAL ADVANCEMENT
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL SUPPLIERS
      • MANUFACTURERS
      • DISTRIBUTORS
      • END-USERS
    • LEGAL, POLICY & REGULATORY FRAMEWORK
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • FRANCE
      • ITALY
      • RUSSIA
      • SPAIN
      • GERMANY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • CORPORATE STRATEGIES
      • PRODUCT LAUNCH
    • COMPANY PROFILES
      • SCIEX
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • BIOTEK INSTRUMENTS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • BIO-RAD LABORATORIES INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • CARDINAL HEALTH INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • GE HEALTHCARE LIMITED
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • AGILENT TECHNOLOGIES INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • MASIMO CORPORATION
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • NATUS MEDICAL INCORPORATED
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • MEDTRONIC PLC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • THERMO FISHER SCIENTIFIC INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • NEOGEN LABS PVT. LTD.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • PERKINELMER INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • ZENTECH S.A.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • WATERS CORPORATION
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • TRIVITRON HEALTHCARE
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS

TABLE LIST

TABLE 1. GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)

TABLE 2. GLOBAL INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS

TABLE 3. LEADING CAUSE OF INFANT DEATH IN THE UNITED STATES

TABLE 4. INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATH/ 1000 LIVE BIRTHS)

TABLE 5. GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)

TABLE 6. GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027, (IN $ MILLION)

TABLE 7. GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)

TABLE 8. OPPORTUNITY MATRIX

TABLE 9. VENDOR LANDSCAPE

TABLE 10. REGULATORY FRAMEWORK

TABLE 11. GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)

TABLE 12. NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 13. EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 14. ASIA PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 15. REST OF WORLD NEWBORN SCREENING MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 16. LIST OF PRODUCT LAUNCHES

FIGURE LIST          

FIGURE 1. GLOBAL NEW-BORN SCREENING INSTRUMENTS MARKET, BY TECHNOLOGY, 2018 & 2027 (IN %)

FIGURE 2. CAUSES OF DEATH AMONG NEWBORNS GLOBALY (0-27 DAYS)

FIGURE 3. FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) 2017

FIGURE 4. GLOBAL NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)

FIGURE 5. GLOBAL NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)

FIGURE 6. GLOBAL NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)

FIGURE 7. GLOBAL NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)

FIGURE 8. GLOBAL NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)

FIGURE 9. GLOBAL NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)

FIGURE 10. GLOBAL NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)

FIGURE 11. GLOBAL NEWBORN SCREENING MARKET, BY ENZYME BASED ASSAYS, 2019-2027 (IN $ MILLION)

FIGURE 12. GLOBAL NEWBORN SCREENING MARKET, BY DNA BASED ASSAYS, 2019-2027 (IN $ MILLION)

FIGURE 13. GLOBAL NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)

FIGURE 14. GLOBAL NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

FIGURE 15. PORTER’S FIVE FORCE ANALYSIS

FIGURE 16. KEY BUYING IMPACT ANALYSIS

FIGURE 17. VALUE CHAIN ANALYSIS

FIGURE 18. GLOBAL NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 19. UNITED STATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 20. CANADA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 21. UNITED KINGDOM NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 22. FRANCE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

FIGURE 23. ITALY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

FIGURE 24. RUSSIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

FIGURE 25. SPAIN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

FIGURE 26. GERMANY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

FIGURE 27. REST OF EUROPE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

FIGURE 28. CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 29. INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 30. JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 31. AUSTRALIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 32. SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

FIGURE 33. REST OF ASIA PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 34. LATIN AMERICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 35. MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 36. INDUSTRY PLAYER POSITIONING IN 2018 (IN %)

  1. MARKET BY PRODUCT
    • NEW-BORN SCREENING INSTRUMENTS
    • NEW-BORN SCREENING REAGENTS & ASSAY KITS
  2. MARKET BY TEST TYPE
    • HEARING SCREEN TEST
    • CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
    • DRY BLOOD SPOT TEST
  3. MARKET BY TECHNOLOGY
    • TANDEM MASS SPECTROMETRY
    • PULSE OXIMETRY
    • ENZYME BASED ASSAYS
    • DNA BASED ASSAYS
    • ELECTROPHORESIS
    • OTHERS
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • FRANCE
      • ITALY
      • RUSSIA
      • SPAIN
      • GERMANY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now